Does Sustanon raw still make sense when single-ester testosterone raws are easier to judge for purity?

In therapy doctors pick esters based on half life and patient preference

Single ester testosterone makes blood levels easier to manage clinically

Combined esters like Sustanon were designed for both fast and sustained release

Medical practice prioritizes stable levels and symptom control

Purity testing of raw powders isn’t a standard clinical concept quality medicines are prescribed

A healthcare provider would choose an FDA approved formulation over raw

Doctors monitor bloodwork to adjust any testosterone therapy

Long-acting esters reduce clinic visits for injections

Treatment decisions weigh symptoms labs and goals

Pharmacists dispense measured quality controlled meds

Patient tolerance to injection frequency matters

The safest approach is consulting a clinician for approved therapy

Esters alone aren’t the whole picture metabolic effects matter

Clinical decisions don’t hinge on raw purity tests

Test levels hematocrit, lipids all get checked in therapy